viewOptiBiotix Health PLC

Investors 'beginning to realise the potential' in OptiBiotix Health - CEO

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI), discusses with Proactive's Andrew Scott the company's recent share price performance and outlines what he's hoping to achieve over the next 6-12 months.

''There really is a big opportunity in the microbiome space which is seen as one of the hottest areas of healthcare''

''While it's a big market, you've got to have the science to deliver and we've won some major awards at industry conferences both in 2017 and 2018 for our science''.

Quick facts: OptiBiotix Health PLC

Price: 65.5 GBX

Market: AIM
Market Cap: £55.96 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...



Full interview: European healthcare broker sets 97p price target for...

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara speaks to Proactive London following a research note whcih has been published on the company by Goetz partners - which has set OPTI a price target of 97p. O'Hara says Goetz partners are a leading European Investment Bank and broking firm and...

on 11/9/19

2 min read